CD40 Ligand antibody (Internal Region)
Quick Overview for CD40 Ligand antibody (Internal Region) (ABIN6260624)
Target
See all CD40 Ligand (CD40LG) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- Internal Region
-
Specificity
- CD40L Antibody detects endogenous levels of total CD40L.
-
Predicted Reactivity
- Bovine,Sheep,Rabbit,Dog
-
Purification
- The antiserum was purified by peptide affinity chromatography using SulfoLinkTM Coupling Resin (Thermo Fisher Scientific).
-
Immunogen
- A synthesized peptide derived from human CD40L, corresponding to a region within the internal amino acids.
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB 1:1000-3000, IF/ICC 1:200-1:500, ELISA(peptide) 1:20000-1:40000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- Rabbit IgG in phosphate buffered saline , pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C. Stable for 12 months from date of receipt.
-
Expiry Date
- 12 months
-
-
- CD40 Ligand (CD40LG)
-
Alternative Name
- CD40LG
-
Background
-
Description: Cytokine that binds to CD40/TNFRSF5 (PubMed:1280226). Costimulates T-cell proliferation and cytokine production. Its cross-linking on T-cells generates a costimulatory signal which enhances the production of IL4 and IL10 in conjunction with the TCR/CD3 ligation and CD28 costimulation (PubMed:8617933). Induces the activation of NF-kappa-B and kinases MAPK8 and PAK2 in T-cells. Induces tyrosine phosphorylation of isoform 3 of CD28 (PubMed:15067037). Mediates B-cell proliferation in the absence of co-stimulus as well as IgE production in the presence of IL4. Involved in immunoglobulin class switching (By similarity).
Gene: CD40LG
-
Molecular Weight
- 36 kDa
-
Gene ID
- 959
-
UniProt
- P29965
-
Pathways
- NF-kappaB Signaling, Production of Molecular Mediator of Immune Response, Cancer Immune Checkpoints
Target
-